Cutaneous soft tissue tumors that make you say, "oh $*&%!"

Advances in Anatomic Pathology

Volumn 19, Issue 5, 2012, Pages 320-330

  Patel, Rajiv M ^a   Billings, Steven D ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

angiomatoid fibrous histiocytoma; angiosarcoma; atypical vascular lesion; cutaneous epithelioid angiomatous nodule; dermatofibrosarcoma protuberans; epithelioid sarcoma; lowgrade fibromyxoid sarcoma

Indexed keywords

ACTIN; CD31 ANTIGEN; CD34 ANTIGEN; CD99 ANTIGEN; CHLORDANE; CYTOKERATIN 7; CYTOKERATIN AE1; CYTOKERATIN AE3; DESMIN; MUCIN 4; TRANSCRIPTION FACTOR FLI 1; VIMENTIN;

ANGIOSARCOMA; CUTANEOUS EPITHELIOID ANGIOMATOUS NODULE; CUTANEOUS SOFT TISSUE TUMOR; DERMATOFIBROSARCOMA PROTUBERANS; DIFFERENTIAL DIAGNOSIS; EPITHELIOID SARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; LOW GRADE FIBROMYXOID SARCOMA; MALIGNANT FIBROUS HISTIOCYTOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SOFT TISSUE TUMOR; TUMOR DIAGNOSIS;

DERMATOFIBROSARCOMA; FIBROSARCOMA; HEMANGIOENDOTHELIOMA, EPITHELIOID; HEMANGIOSARCOMA; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; IMMUNOHISTOCHEMISTRY; MUCINS; PROGNOSIS; SARCOMA; SKIN NEOPLASMS; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84865477355     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e31826661d1     Document Type: Review

References (71)

1. Enzinger FM. Angiomatoid malignant fibrous histiocytoma: a distinct fibrohistiocytic tumor of children and young adults simulating a vascular neoplasm. Cancer. 1979;44:2147-2157. (Pubitemid 10210845)
2. Chen G, Folpe AL, Colby TV, et al. Angiomatoid fibrous histiocytoma: unusual sites and unusual morphology. Mod Pathol. 2011;24:1560-1570.
3. Thway K, Nicholson AG, Wallace WA, et al. Endobronchial pulmonary angiomatoid fibrous histiocytoma: two cases with EWSR1-CREB1 and EWSR1-ATF1 fusions. Am J Surg Pathol. 2012;36:883-888.
4. Asakura S, Tezuka N, Inoue S, et al. Angiomatoid fibrous histiocytoma in mediastinum. Ann Thorac Surg. 2001;72:283-285. (Pubitemid 32643066)
5. Song JY, Lee SK, Kim SG, et al. Angiomatoid fibrous histiocytoma on the hard palate: case report. Oral Maxillofac Surg. 2012;16:237-242.
6. Mangham DC, Willimas A, Lalam RK, et al. Angiomatoid fibrous histiocytoma of bone: a calcifying sclerosing variant mimicking osteosarcoma. Am J Surg Pathol. 2010;34:279-285.
7. Caballero LR, Rodriguez AC, Sopelana AB. Angiomatoid malignant fibrous histiocytoma of the orbit. Am J Ophthalmol. 1981;92:13-15.
8. Costa MJ, Weiss SW. Angiomatoid malignant fibrous histiocytoma. A follow-up study of 108 cases with evaluation of possible histologic predictors of outcome. Am J Surg Pathol. 1990;14:1126-1132.
9. Fanburg-Smith JC, Miettinen M. Angiomatoid "malignant" fibrous histiocytoma: a clinicopathologic study of 158 cases and further exploration of the myoid phenotype. Hum Pathol. 1999;30:1336-1343. (Pubitemid 29534296)
10. Weinreb I, Rubin BP, Goldblum JR. Pleomorphic angiomatoid fibrous histiocytoma: a case confirmed by fluorescence in situ hybridization analysis for EWSR1 rearrangement. J Cutan Pathol. 2008;35:855-860.
11. Raddaoui E, Donner RL, Panagopoulos I. Fusion of the FUS and ATF1 genes in a large, deep-seated angiomatoid fibrous histiocytoma. Diagn Mol Pathol. 2002;11:157-162.
12. Rossi S, Szuhai K, Ijszenga M, et al. EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma. Clin Cancer Res. 2007;13:7322-7328.
13. Antonescu CR, Dal Cin P, Nafa K, et al. EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer. 2007;46:1051-1060. (Pubitemid 47614539)
14. Tanas MR, Rubin BP, Montgomery EA, et al. Utility of FISH in the diagnosis of angiomatoid fibrous histiocytoma: a series of 18 cases. Mod Pathol. 2010;23:93-97.
15. Santa Cruz DJ, Kyriakos M. Aneurysmal ("angiomatoid") fibrous histiocytoma of the skin. Cancer. 1981;47:2053-2061. (Pubitemid 11153446)
16. Weiss SW, Goldblum JR. Fibrohistiocytic tumors of intermediate malignancy. Enzinger and Weiss's Soft Tissue Tumors. Philadelphia: Elsevier; 2008:371-390.
17. Frierson HF, Cooper PH. Myxoid variant of dermatofibrosarcoma protuberans. Am J Surg Pathol. 1983;7:445-450. (Pubitemid 13006790)
18. Reimann JD, Fletcher CD. Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases. Am J Surg Pathol. 2007;31:1371-1377. (Pubitemid 47329674)
19. Mentzel T, Schärer L, Kazakov DV, et al. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases. Am J Dermatopathol. 2007;29:443-448. (Pubitemid 47463852)
20. Weiss SW, Goldblum JR. Liposarcoma. Enzinger and Weiss's Soft Tissue Tumors. Philadelphia: Elsevier; 2008:498-510.
21. Calonje E, Guerin D, McCormick D, et al. Superficial angiomyxoma: clinicopathologic analysis of a series of distinctive but poorly recognized cutaneous tumors with tendency for recurrence. Am J Surg Pathol. 1999;23:910-917. (Pubitemid 29360108)
22. Enzinger FM. Epithelioid sarcoma. A sarcoma simulating a granuloma or a carcinoma. Cancer. 1970;26:1029-1041.
23. Chase DR, Enzinger FM. Epithelioid sarcoma. Diagnosis, prognostic indicators and treatment. Am J Surg Pathol. 1985;9:241-263. (Pubitemid 15037676)
24. Cassanova M, Ferrari A, Collini P, et al. Epithelioid sarcoma in children and adolescents: a report from the Italian Soft Tissue Sarcoma Committee. Cancer. 2006;106:708-717. (Pubitemid 43157636)
25. Mirra JM, Kessler S, Bhuta S, et al. The fibroma-like variant of epithelioid sarcoma. A fibrohistiocytic/myoid cell lesion often confused with benign and malignant spindle cell tumors. Cancer. 1992;69:1382-1395.
26. Guillou L, Wadden C, Coindre JM, et al. "Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series. Am J Surg Pathol. 1997;21:130-146. (Pubitemid 27084052)
27. Hasegawa T, Matsuno Y, Shmoda T, et al. Proximal-type epithelioid sarcoma: a clinicopathologic study of 20 cases. Mod Pathol. 2001;14:655-663. (Pubitemid 32667209)
28. Laskin WB, Miettinen M. Epithelioid sarcoma: new insights based on an extended immunohistochemical analysis. Arch Pathol Lab Med. 2003;127:1161-1168. (Pubitemid 37093265)
29. Hornick JL, Dal Cin P, Fletcher CD. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Am J Surg Pathol. 2009;33:542-550.
30. Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer. 1982;50:970-981. (Pubitemid 12047134)
31. Weiss SW, Ishak KG, Dail DH, et al. Epithelioid hemangioendothelioma and related lesions. Semin Diagn Pathol. 1986;3:259-287.
32. Quante M, Patel NK, Hill S, et al. Epithelioid hemangioendothelioma presenting in the skin: a clinicopathologic study of eight cases. Am J Dermatopathol. 1998;20:541-546. (Pubitemid 28549457)
33. Gray MH, Rosenberg AE, Dickersin GR, et al. Cytokeratin expression in epithelioid vascular neoplasms. Hum Pathol. 1990;21:212-217. (Pubitemid 20087165)
34. Tanas MR, Sboner A, Oliveira AM, et al. Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma. Sci Transl Med. 2011;3:98-82.
35. Errani C, Zhang L, Sung YS, et al. A novel WWTR1CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosomes Cancer. 2011;50:644-653.
36. Hornick JL, Fletcher CD. Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior. Am J Surg Pathol. 2011;35:190-201.
37. Billings SD, Folpe AL, Weiss SW. Epithelioid sarcoma-like hemangioendothelioma. Am J Surg Pathol. 2003;27:48-57. (Pubitemid 36014898)
38. Brenn T, Fletcher CD. Cutaneous epithelioid angiomatous nodule: a distinct lesion in the morphologic spectrum of epithelioid vascular tumors. Am J Dermatopathol. 2004;26:14-21. (Pubitemid 38116538)
39. Sangueza OP, Walsh SN, Sheehan DJ, et al. Cutaneous epithelioid angiomatous nodule: a case series and proposed classification. Am J Dermatopathol. 2008;30:16-20. (Pubitemid 351161624)
40. Fetsch JF, Weiss SW. Observations concerning the pathogenesis of epithelioid hemangioma (angiolymphoid hyperplasia). Mod Pathol. 1991;4:449-455.
41. Suchak R, Thway K, Zelger B, et al. Primary cutaneous epithelioid angiosarcoma: a clinicopathologic study of 13 cases of a rare neoplasm occurring outside the setting of conventional angiosarcomas and with predilection for the limbs. Am J Surg Pathol. 2011;35:60-69.
42. Fletcher CD, Beham A, Bekir S, et al. Epithelioid angiosarcoma of deep soft tissue: a distinctive tumor readily mistaken for an epithelial neoplasm. Am J Surg Pathol. 1991;15:915-924.
43. Billings SD, McKenneu JK, Folpe AL, et al. Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases. Am J Surg Pathol. 2004;28:781-788. (Pubitemid 38685892)
44. Brenn T, Fletcher CD. Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopathologic analysis of 42 cases. Am J Surg Pathol. 2005;29:983-996. (Pubitemid 41045542)
45. Deyrup AT, Mckenney JK, Tighiouart M, et al. Sporadic cutaneous angiosarcomas: a proposal for risk stratification based on 69 cases. Am J Surg Pathol. 2008;32:72-77.
46. Patton KT, Deyrup AT, Weiss SW. Atypical vascular lesions after surgery and radiation of the breast: a clinicopathologic study of 32 cases analyzing histologic heterogeneity and association with angiosarcoma. Am J Surg Pathol. 2008;32:943-950.
47. Deyrup AT, Miettinen M, North PE, et al. Angiosarcomas arising in the viscera and soft tissue of children and young adults: a clinicopathologic study of 15 cases. Am J Surg Pathol. 2009;33:264-269.
48. Abrahamson TG, Stone MS, Piette WW. Cutaneous angiosarcoma. Adv Dermatol. 2001;17:279-299.
49. Morgan MB, Swann M, Somach S, et al. Cutaneous angiosarcoma: a case series with prognostic correlation. JAm Acad Dermatol. 2004;50:867-874. (Pubitemid 38685765)
50. McKenney JK, Weiss SW, Folpe AL. CD31 expression in intratumoral macrophages: a potential diagnostic pitfall. Am J Surg Pathol. 2001;25:1167-1173. (Pubitemid 32777716)
51. Folpe AL, Chand EM, Goldblum JR, et al. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics. Am J Surg Pathol. 2001;25:1061-1066. (Pubitemid 32685904)
52. Miettinen M, Wang ZF, Paerau A, et al. ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma. Am J Surg Pathol. 2011;35:432-441.
53. Patel RM, Goldblum JR, Hsi ED. Immunohistochemical detection of human herpes virus-8 latent nuclear antigen-1 is useful in the diagnosis of Kaposi sarcoma. Mod Pathol. 2004;17:456-460. (Pubitemid 41646601)
54. Mattoch IW, Robbins JB, Kempson RL, et al. Post-radiotherapy vascular proliferations in mammary skin: a clinicopathologic study of 11 cases. JAmAcadDermatol. 2007;57:126-133. (Pubitemid 46899264)
55. Manner J, Radlwimmer B, Hohenberger P, et al. MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema. Am J Pathol. 2010;176:34-39.
56. Mentzel T, Schildhaus HU, Palmedo G, et al. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases. Mod Pathol. 2012;25:75-85.
57. Fernandez AP, Sun Y, Tubbs RR, et al. FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations. J Cutan Pathol. 2012;39:234-242.
58. Evans HL. Low-grade fibromyxoid sarcoma. A report of 12 cases. Am J Surg Pathol. 1993;17:595-600. (Pubitemid 23152597)
59. Evans HL. Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance. Am J Clin Pathol. 1987;88:615-619. (Pubitemid 18014621)
60. Lane KL, Shannon RJ, Weiss SW. Hyalinizing spindle cell tumor with giant rosettes: a distinctive tumor closely resembling low-grade fibromyxoid sarcoma. Am JSurgPathol. 1997;21:1481-1488. (Pubitemid 27528259)
61. Folpe AL, Lane KL, Paull G, et al. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas. Am J Surg Pathol. 2000;24:1353-1360.
62. Storlazzi CT, Mertens F, Nascimento A, et al. Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcoma. Hum Mol Genet. 2003;12:2349-2358. (Pubitemid 37160879)
63. Reid R, de Silva MV, Paterson L, et al. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes share a common t (7;16) (q34;p11) translocation. Am J Surg Pathol. 2003;27:1229-1236. (Pubitemid 37040585)
64. Panagopoulos I, Storlazzi CT, Fletcher CD, et al. The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma. Genes Chromosomes Cancer. 2004;40:218-228. (Pubitemid 38703098)
65. Mertens F, Fletcher CD, Antonescu CD, et al. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab Invest. 2005;85:408-415. (Pubitemid 40333157)
66. Billings SD, Giblen G, Fanburg-Smith JC. Superficial lowgrade fibromyxoid sarcoma (Evans tumor): a clinicopathologic analysis of 19 cases with a unique observation in the pediatric population. Am J Surg Pathol. 2005;29:204-210. (Pubitemid 40170638)
67. Oda Y, Takahira T, Kawaguchi K, et al. Low-grade fibromyxoid sarcoma versus low-grade myxofibrosarcoma in the extremities and trunk. A comparison of clinicopathological and immunohistochemical features. Histopathology. 2004;45:29-38. (Pubitemid 38969559)
68. Doyle LA, Möller E, Dal Cin P, et al. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Am J Surg Pathol. 2011;35:733-741.
69. Downs-Kelly E, Goldblum JR, Patel RM, et al. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms. Am J Surg Pathol. 2008;32:8-13.
70. Patel RM, Downs-Kelly E, Dandekar MN, et al. FUS (16p11) gene rearrangement as detected by fluorescence in-situ hybridization in cutaneous low-grade fibromyxoid sarcoma: a potential diagnostic tool. Am J Dermatopathol. 2011;33:140-143.
71. Thway K, Fisher C, Debied-Rychter M, et al. Claudin-1 is expressed in perineurioma-like low-grade fibromyxoid sarcoma. Hum Pathol. 2009;40:1586-1590.